The hypothesis is that inactivation of CXCL12 by NOX-A12 induces changes in the tumor microenvironment of patients with CRC and pancreatic cancer, which would render tumors more susceptible to checkpoint inhibition [159]. This evidence concerns the gene CXCL12 and neoplasm.